Bio-Works Technologies AB (publ) (FRA:1BD)

Market Cap	27.00M +38.4%
Revenue (ttm)	8.10M +126.5%
Net Income	199.14K
EPS	0.00
Shares Out	n/a
PE Ratio	121.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	385
Open	0.2580
Previous Close	0.2650
Day's Range	0.2580 - 0.2580
52-Week Range	0.1800 - 0.4140
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2006
• Employees: 32
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1BD

Financial Performance

In 2025, Bio-Works Technologies AB's revenue was 62.50 million, an increase of 105.02% compared to the previous year's 30.49 million. Losses were -15.25 million, -59.19% less than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error